Based on interview and record review, the facility did not accurately complete required Preadmission Screen and Resident Review (PASRR) Level I and/or Level II screens to determine appropriate placement to the facility, or need for specialized services for 1 of 1 resident reviewed (R7).R7 was admitted with unspecified lack of expected normal physiological development in childhood and Developmental Delay. The facility failed to appropriately complete a PASRR Level 1 screen with a short-term exemption from a Level 2 screen as R7 planned to reside less than 30 days in the facility.This is Evidenced by:R7 was admitted to the facility on [DATE] with a diagnosis of R62.50 Unspecified lack of expected normal physiological development in childhood and Developmental Delay.The facility's policy,… …
F645 citations in Wisconsin
PASARR screening · Resident Assessment and Care Planning Deficiencies
PASARR screening for Mental disorders or Intellectual Disabilities
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Wisconsin cites F645 more often than its own record predicts
1.44 times the share F645 takes of citations nationally.
Of every deficiency written in Wisconsin in 2025, this is the portion that was F645.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Wisconsin surveyors wrote
F645 findings written in Wisconsin, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on record review and interview, the facility did not complete a Level 2 PASARR (Preadmission Screen and Resident Review) for 3 of 3 (R17, R6, R13) sampled residents. The facility did not complete a Level 2 PASARR to determine needs for specialized services for R17, R6 and R13. This is evidenced by: Surveyor reviewed R17's record and noted R17 was admitted [DATE] with diagnosis [MEDICAL RECORD OR PHYSICIAN ORDER] . R17's medications include: 2/21/22: [MEDICATION(S)] 150 mg ER 1 tablet by mouth at bedtime for [CONDITION(S)] 2/21/22: [MEDICATION(S)] 0.5 mg 1 tablet twice a day for generalized anxiety 2/21/22 [MEDICATION(S)] 20 mg 1 capsule every day for [CONDITION(S)] disorder, depressive type Resident County review of nursing home referral indicates R17 was granted a hospital… …
The short window
Recent years
| Year | Share of Wisconsin citations | vs expected |
|---|---|---|
| 2023 | 1.00% | 1.72× |
| 2024 | 0.70% | 1.10× |
| 2025 | 0.87% | 1.44× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else Wisconsin surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction